Zwerling, Schachter & Zwerling LLP, concentrates on matters, involving complex litigation. These include securities, antitrust, deceptive trade practice, and consumer fraud class action.
Zwerling Schachter has built a nationwide reputation successfully prosecuting high-profile and ground-breaking cases.
Courts have often appointed Zwerling Schachter as lead counsel in complex matters.
Our attorneys have extensive experience trying cases in federal and state courts and representing a wide variety of public, private, corporate, and individual clients.
Two families who sued Lloyd’s of London underwriters in a class action over claims for benefits stemming from a Hawaii volcano eruption want to be excluded from a $22 million settlement...
A group of Restasis buyers on Friday defended class certification in their New York federal suit accusing Allergan of boosting profits ...
Takeda Pharmaceutical Co. Ltd. asked a Manhattan federal judge to let it immediately appeal two rulings greenlighting claims that the drugmaker delayed generic competition for the diabetes medication Actos...
End payors and direct buyers of the diabetes drug Actos have urged a New York federal judge to nix Takeda’s bid to immediately appeal her decision preserving some class action claims against the drugmaker...
Health care plans, welfare funds and other buyers of Allergan's extremely successful dry eye treatment Restasis have won class certification in the sweeping litigation accusing the drugmaker of illegally keeping generic rivals on the sidelines, with three firms tapped to head up their legal team.